@article { WOS:000457450900001,
	title = {Tofacitinib Synthesis - An Asymmetric Challenge},
	journal = {EUROPEAN JOURNAL OF ORGANIC CHEMISTRY},
	volume = {2019},
	number = {4},
	year = {2019},
	note = {n/a},
	month = {JAN 31},
	pages = {615-624},
	abstract = {<p>Tofacitinib is a Janus activated kinase (JAK) inhibitor approved for the treatment of rheumatoid arthritis and active psoriatic arthritis. Its synthesis normally involves long synthetic sequences due to the chirality associated to the piperidine ring. This review is a comprehensive analysis of the different synthetic methods used to prepare this active pharmaceutical ingredient (API), covering the related journal and patent literature.</p>
},
	issn = {1434-193X},
	doi = {10.1002/ejoc.201801180},
	author = {Carvalho, Luisa C. R. and Lourenco, Ana and Ferreira, Luisa Maria and Branco, Paula Serio}
}
